J&J: AMONG PATIENTS WITH QUALIFYING SKIN INVOLVEMENT, 57% RECEIVING ICOTYDE ACHIEVED CLEAR/ALMOST CLEAR SKIN VS 14% PLACEBO

Reuters · 1d ago

Please log in to view news